These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1988 related articles for article (PubMed ID: 33942327)

  • 41. Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study.
    Zhang X; Lu S; Li H; Wang Y; Lu Z; Liu Z; Lai Q; Ji Y; Huang X; Li Y; Sun J; Wu Y; Xu X; Hou J
    Virol Sin; 2020 Dec; 35(6):820-829. PubMed ID: 33351168
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SARS-CoV-2 RNAaemia in children: An Iranian referral hospital-based study.
    Pourakbari B; Mahmoudi S; Mahmoudieh Y; Eshaghi H; Navaeian A; Rostamyan M; Mamishi S
    J Med Virol; 2021 Sep; 93(9):5452-5457. PubMed ID: 33969515
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinetics of viral load and antibody response in relation to COVID-19 severity.
    Wang Y; Zhang L; Sang L; Ye F; Ruan S; Zhong B; Song T; Alshukairi AN; Chen R; Zhang Z; Gan M; Zhu A; Huang Y; Luo L; Mok CKP; Al Gethamy MM; Tan H; Li Z; Huang X; Li F; Sun J; Zhang Y; Wen L; Li Y; Chen Z; Zhuang Z; Zhuo J; Chen C; Kuang L; Wang J; Lv H; Jiang Y; Li M; Lin Y; Deng Y; Tang L; Liang J; Huang J; Perlman S; Zhong N; Zhao J; Malik Peiris JS; Li Y; Zhao J
    J Clin Invest; 2020 Oct; 130(10):5235-5244. PubMed ID: 32634129
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristics and Outcomes Based on Perceived Illness Severity in SARS-CoV-2.
    Snipelisky D; Johnson R; Prasad R; Lakhani B; Ellington J
    South Med J; 2020 Dec; 113(12):618-622. PubMed ID: 33263129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and therapeutic outcomes of COVID-19 intensive care units (ICU) patients: a retrospective study in Ghana.
    Afriyie-Mensah J; Aboagye ET; Ganu VJ; Bondzi S; Tetteh D; Kwarteng E; Akamah J; Doku A; Adjei P
    Pan Afr Med J; 2021; 38():107. PubMed ID: 33912277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19.
    Miki S; Sasaki H; Horiuchi H; Miyata N; Yoshimura Y; Miyazaki K; Matsumura T; Takahashi Y; Suzuki T; Matano T; Kawana-Tachikawa A; Tachikawa N
    PLoS One; 2021; 16(7):e0254640. PubMed ID: 34255796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combining predictive markers for severe COVID-19: Torquetenovirus DNA load and SARS-CoV-2 RNAemia.
    Solis M; Gallais F; Garnier-Kepka S; Lefebvre N; Benotmane I; Ludes PO; Castelain V; Meziani F; Caillard S; Collange O; Fafi-Kremer S
    J Clin Virol; 2022 Mar; 148():105120. PubMed ID: 35227970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of cardiometabolic microRNAs with COVID-19 severity and mortality.
    Gutmann C; Khamina K; Theofilatos K; Diendorfer AB; Burnap SA; Nabeebaccus A; Fish M; McPhail MJW; O'Gallagher K; Schmidt LE; Cassel C; Auzinger G; Napoli S; Mujib SF; Trovato F; Sanderson B; Merrick B; Roy R; Edgeworth JD; Shah AM; Hayday AC; Traby L; Hackl M; Eichinger S; Shankar-Hari M; Mayr M
    Cardiovasc Res; 2022 Jan; 118(2):461-474. PubMed ID: 34755842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of high SARS-CoV-2 RNAemia with diabetes and mortality in critically ill COVID-19 patients.
    Monchi M; Bruneau T; Jochmans S; Veyer D; Pitsch A; Ellrodt O; Picque M; Taly V; Sy O; Mazerand S; Diamantis S; Péré H
    iScience; 2022 May; 25(5):104075. PubMed ID: 35309726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma SARS-CoV-2 RNA Levels as a Biomarker of Lower Respiratory Tract SARS-CoV-2 Infection in Critically Ill Patients With COVID-19.
    Jacobs JL; Naqvi A; Shah FA; Boltz VF; Kearney MF; McVerry BJ; Ray P; Schaefer C; Fitzpatrick M; Methé B; Lee JS; Morris A; Mellors JW; Kitsios GD; Bain W
    J Infect Dis; 2022 Dec; 226(12):2089-2094. PubMed ID: 35511031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Convalescent plasma is a clutch at straws in COVID-19 management! A systematic review and meta-analysis.
    Sarkar S; Soni KD; Khanna P
    J Med Virol; 2021 Feb; 93(2):1111-1118. PubMed ID: 32776573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and efficacy of convalescent plasma as a therapy for SARS-CoV-2: A systematic review and meta-analysis.
    Choudhuri AH; Duggal S; Singh J; Biswas PS
    J Anaesthesiol Clin Pharmacol; 2022 Jul; 38(Suppl 1):S22-S33. PubMed ID: 36060163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Duration of SARS-CoV-2 viremia and its correlation to mortality and inflammatory parameters in patients hospitalized for COVID-19: a cohort study.
    Hagman K; Hedenstierna M; Rudling J; Gille-Johnson P; Hammas B; Grabbe M; Jakobsson J; Dillner J; Ursing J
    Diagn Microbiol Infect Dis; 2022 Mar; 102(3):115595. PubMed ID: 34896666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequent detection but lack of infectivity of SARS-CoV-2 RNA in presymptomatic, infected blood donor plasma.
    Saá P; Fink RV; Bakkour S; Jin J; Simmons G; Muench MO; Dawar H; Di Germanio C; Hui AJ; Wright DJ; Krysztof DE; Kleinman SH; Cheung A; Nester T; Kessler DA; Townsend RL; Spencer BR; Kamel H; Vannoy JM; Dave H; Busch MP; Stramer SL; Stone M; Jackman RP; Norris PJ;
    J Clin Invest; 2022 Sep; 132(17):. PubMed ID: 35834347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and feasibility of physiotherapy in ICU-admitted severe COVID-19 patients: an observational study.
    Rossi V; Santambrogio M; Del Monaco C; Retucci M; Tammaro S; Ceruti C; Saderi L; Aliberti S; Privitera E; Grasselli G; Sotgiu G; Blasi F
    Monaldi Arch Chest Dis; 2022 Jan; 92(4):. PubMed ID: 35086328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of SARS-CoV-2 RNAemia and other risk factors on long-COVID: A prospective observational multicentre cohort study.
    Rombauts A; Infante C; de Lagos MDÁM; Alba J; Valiente A; Donado-Mazarrón C; Carretero-Ledesma M; Rodríguez-Álvarez R; Omatos S; Palacios-Baena ZR; Abelenda-Alonso G; Silva-Sánchez MDM; Goikoetxea-Agirre AJ; Oteo JA; Rodríguez-Baño J; Cordero E; Gudiol C; Sánchez-Céspedes J; Carratalà J
    J Infect; 2023 Feb; 86(2):154-225. PubMed ID: 36403699
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19.
    Raychaudhuri D; Bandopadhyay P; D'Rozario R; Sarif J; Ray Y; Paul SR; Singh P; Chaudhuri K; Bhaduri R; Pandey R; Bhattacharya P; Sengupta S; Chatterjee S; Ganguly D
    Mayo Clin Proc Innov Qual Outcomes; 2022 Dec; 6(6):511-524. PubMed ID: 36117954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness of Convalescent Plasma Therapy in COVID-19 Patients with Hematological Malignancies: A Systematic Review.
    Shibeeb S; Ajaj I; Al-Jighefee H; Abdallah AM
    Hematol Rep; 2022 Dec; 14(4):377-388. PubMed ID: 36547236
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of convalescent plasma transfusion on outcomes of coronavirus disease 2019: a meta-analysis with trial sequential analysis.
    Hakim SM; Chikhouni GMA; Ammar MA; Amer AM
    J Anesth; 2023 Jun; 37(3):451-464. PubMed ID: 36811668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 100.